Nanotechnology
that acts on
human life.
Bionano Research is an applied nanobiotechnology company engineering a new layer of medicine — one that acts beneath the surface of skin, blood and matter. We build tools that intervene before disease begins, that carry the clinical lab into a pocket, and that rewrite what structural materials can do.
An applied nanobiotech company rebuilding what medicine and materials can do.
Mission. Develop cutting-edge nanotechnology solutions that transform preventive medicine, clinical diagnostics and advanced materials — with direct impact on human quality of life.
Vision. To be the global benchmark in medical nanobiotechnology, leading the transition toward proactive, personalised medicine — and positioning structural nanomaterials as the standard of advanced industry.
Biomedical Nanotechnology
Active formulations with nanoparticles that act at the cellular level to protect, repair and optimise the human body.
Cutting-Edge Diagnostics
Ultra-fast analysis platforms that bring the clinical lab to the point of care — in seconds, not hours.
Intelligent Structural Materials
Next-generation nanocomposites with mechanical, thermal and electromagnetic properties impossible with conventional materials.
Medicine and materials have reached their ceiling. We break it at the nano scale.
Reactive Medicine
Health systems treat symptoms instead of preventing and optimising human biology. We need tools that act before disease appears.
Slow, Costly Diagnostics
Current clinical tests take 3–24 hours and depend on expensive hospital infrastructure — delaying decisions that can cost lives.
Inflammation & Oxidative Stress
The root of most degenerative diseases. No nanotechnology-grade pharmacological answers exist at wide scale.
Materials at Physical Limits
Steel, aluminium and carbon fibre are near their ceiling. Defence, aerospace and automotive require a paradigm shift.
Three divisions. Five projects.
One commitment to human life.
ELI7EK.
Next-generation dermal nanoprotector. An active physical and biological barrier built from nanoparticles, hyaluronic acid and amino acids — worn on the skin, working at the cellular level from the first application.
GAMMA.
A portable AI optical bioanalyzer — the size of a calculator — that turns a single drop of capillary blood into a full clinical read-out in real time.
BETA.
Critical-response hemostatic nanofoam. Topical bioactive nanoparticles that initiate coagulation in seconds , form an antimicrobial barrier and reduce pain during emergency care.
DELTA.
Non-genetic bioactive intravenous therapy for functional optimisation, systemic resilience and cellular regeneration. Built for high-performance profiles, anti-ageing medicine and elite recovery.
AEGIS·X.
Next-generation structural composite nanomaterials — for defence, aerospace and automotive , where steel, aluminium and carbon fibre have already hit their physical ceiling.
AEGIS-X Structural
Base variant for maximum mechanical performance. The highest structural resistance of the family, for applications where integrity and weight are critical.
AEGIS-X Solar
Structural base with integrated photovoltaic layer. Generates energy without sacrificing mechanical properties. Ideal for vehicles, satellites and autonomous structures.
AEGIS-X Pure
Particle filtration integrated into the composite matrix. Environmental and structural protection in a single material — for high-pollution or biological environments.
A multidisciplinary team spanning science, diplomacy, law and industry.
In collaboration with institutions that define international deep tech.
Strategic partners for scientific validation, applied research and global expansion.
This network keeps growing. We continue adding strategic allies to extend the reach of our research.
Back the transition to proactive medicine.
We're raising alongside strategic partners in deep medtech and advanced materials. Register below and our founding team will reach out with the investor dossier and a confidential data-room invitation.